U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854783) titled 'Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers' on Feb. 14.
Brief Summary: The purpose of this study is to assess the pharmacokinetics, safety, tolerability and food effect of investigational drug MRX1 in healthy adults.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Pharmacokinetics
Intervention:
DRUG: Cannabidiol 100 MG/ML
Cannabidiol 100mg/ml oral solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tiamat Australia Pty Ltd
Published by HT Digital Content Services with permission from Health Daily Digest....